Another win for VitalTrace through BioMedTech Horizons

VitalTrace and our associated partners are honoured to announce that our BioMedTech Horizons bid has been successfully awarded a $797,276 grant from the MTPConnect and Dr Daniel Grant. This funding will accelerate VitalTrace's capacity to create prototype devices, fast-tracking our steps to commercialisation ready for advanced manufacturing and clinical trials activity.

MTPConnect Managing Director and CEO, Dr Daniel Grant, says this round focused predominantly on the development of pre-commercial prototypes that are entering human clinical trials.

“From the five selected projects, patients of the future are set to benefit from new medical devices for blindness and vision impairment, improved neonatal resuscitation, precision monitoring of fetal complications during birth, real-time atrial fibrillation/cardiac monitoring for patients at home and patient matched spinal implants,” Dr Grant said.

Read the announcement here.

We are excited by the opportunity this funding presents to improve the future of childbirth monitoring!